Why the study?
Do ACE inhibitors prevent the progression of renal failure and development of macroalbuminuria in patients with diabetes mellitus?
Population
Patients with diabetes mellitus
Design
Review
Authors
Loading...
Supports ACE inhibitor preference in diabetic nephropathy; extends prior data but hypothesis-generating pending prospective trials.
Do ACE inhibitors prevent the progression of renal failure and development of macroalbuminuria in patients with diabetes mellitus?
ACE inhibitors provide renoprotective benefits beyond blood pressure lowering and are considered the drugs of choice in diabetic patients with hypertension or renal dysfunction.
Luís M. Ruilope (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: